Bon Natural Life (BON) AI Stock Analysis

• Market Cap: $1.94M
• Dividend Yield: N/A
• Average Volume (3M): 6.71M
• Price to Earnings (P/E): 3.4
• Beta (1Y): 1.42
• Revenue Growth: -19.23%
• EPS Growth: -77.24%
• Country: US
• Employees: 97
• Sector: Consumer Defensive
• Sector Strength: 65
• Industry: Consumer Products - Foods
• EPS (TTM): 0.10
• Shares Outstanding: 4,170,558
• 10 Day Avg. Volume: 19,489,263
• 30 Day Avg. Volume: 6,714,508
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.06
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Bon Natural Life faces significant challenges, with declining revenues, profitability, and negative cash flows impacting its financial performance. The technical analysis indicates a bearish trend, raising caution for potential investors. Despite a low P/E ratio suggesting potential undervaluation, the lack of dividend yield diminishes its attractiveness. The company must focus on improving revenue generation and cash flow efficiency to enhance its financial health and investor confidence.

Bon Natural Life Business Overview & Revenue Model

Company Description

Broadstone Net Lease Inc is a real estate investment trust. It acquires, owns, and manages primarily single-tenant commercial real estate properties that are net leased on a long-term basis. The company invests in industrial, healthcare, restaurant, office, and retail properties.

How the Company Makes Money

Bon Natural Life makes money through the sale of its products, which are distributed to various industries such as pharmaceuticals, cosmetics, and food and beverage. The company generates revenue by supplying these natural ingredients and products to manufacturers who use them in their own product lines. Key revenue streams include direct sales to companies in the aforementioned sectors and potentially through partnerships or collaborations that allow for expanded distribution and market reach. BON's focus on natural and health-conscious products aligns with growing consumer trends, contributing to its earnings potential.

Bon Natural Life Financial Statement Overview

Summary

Bon Natural Life exhibits a challenging financial landscape with declining revenues and profitability, coupled with negative cash flows. While the company maintains a strong equity position, operational and liquidity issues could pose risks to future financial health. The company needs to address revenue generation and cash flow efficiency to improve its financial standing.

Income Statement

The income statement shows a declining trend in revenue with a significant drop in net income over the past year. The gross profit margin for the latest annual period is approximately 29.8%, which is decent but overshadowed by the steep decline in both EBIT and net profit margins, indicating pressure on profitability. The revenue growth rate is negative, highlighting a challenging environment for revenue generation.

Balance Sheet

The balance sheet reflects a strong equity position with a debt-to-equity ratio of approximately 0.17, indicating low leverage. The return on equity (ROE) is around 0.9%, suggesting limited profitability relative to equity. The equity ratio stands at about 71.1%, showcasing strong financial stability, but the declining asset base and increasing liabilities are potential concerns.

Cash Flow

The cash flow statement is concerning, with negative operating and free cash flows, indicating strained liquidity. The operating cash flow to net income ratio is negative, pointing to operational challenges in generating cash relative to reported income. The free cash flow growth rate is also negative, highlighting deteriorating cash flow conditions.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
30.65M	23.84M	29.52M	29.91M	25.49M	18.22M
	Gross Profit
8.58M	7.11M	8.84M	9.42M	7.11M	5.20M
	EBIT
3.06M	1.87M	5.92M	6.54M	5.40M	3.47M
	EBITDA
4.76M	2.30M	6.98M	8.33M	6.13M	3.70M
	Net Income Common Stockholders
2.46M	398.17K	4.60M	6.24M	4.59M	3.03M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
717.88K	80.47K	112.82K	840.86K	3.61M	53.11K
	Total Assets
50.08M	61.77M	46.56M	37.26M	36.41M	25.20M
	Total Debt
6.66M	7.30M	4.20M	5.41M	3.06M	5.72M
	Net Debt
5.94M	7.22M	4.09M	4.57M	1.16M	5.67M
	Total Liabilities
12.76M	17.42M	10.57M	7.16M	9.88M	14.18M
	Stockholders Equity
36.69M	43.91M	35.48M	29.56M	26.01M	10.52M
Cash Flow		Free Cash Flow
-1.81M	-7.73M	-1.38M	-4.92M	-700.78K	-1.69M
	Operating Cash Flow
-1.30M	-7.72M	-651.91K	-187.12K	4.05M	2.64M
	Investing Cash Flow
-1.17M	-15.73K	-1.19M	-3.06M	-7.44M	-3.00M
	Financing Cash Flow
3.01M	8.76M	1.16M	2.26M	5.35M	112.49K

Bon Natural Life Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.35
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BON, the sentiment is Negative. The current price of 0.35 is below the 20-day moving average (MA) of 0.88, below the 50-day MA of 1.19, and below the 200-day MA of 1.67, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 33.77 is Neutral, neither overbought nor oversold. The STOCH value of 0.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BON.

Bon Natural Life Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SENEA	71 Outperform	$589.60M	15.94	6.35%	―	4.01%	22.46%
JJSF	64 Neutral	$2.55B	30.17	9.08%	2.32%	2.14%	5.38%
Sector *	62 Neutral	$20.59B	13.95	-9.90%	7.34%	1.61%	7.08%
FARM	61 Neutral	$46.12M	―	-23.75%	―	-9.51%	83.29%
THS	54 Neutral	$1.40B	49.34	1.67%	―	-4.59%	-42.81%
BON	53 Neutral	$1.94M	3.43	1.05%	―	-19.23%	-77.24%
HFFG	47 Neutral	$147.14M	―	-18.45%	―	4.63%	-2188.56%